glp-1 and ckd Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes Safety of SGLT2i and RAs SGLT2 vs GLP-1 for CKD:

Foretz M, Guigas B, Viollet B (2019) Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus

We can adjust your medication dosage if you begin to feel unwanted side effects

The complex interaction relationship between iron metabolism disorders and changes in the abundance of gut microbiota (especially Bifidobacterium ) revealed in this section provides evidence for clarifying the molecular mechanism of the hypothetical pathological axis of iron overload-disruption of gut homeostasis-ferroptosis in OA, and suggests that targeted regulation of the iron-microbiota interaction may become a potential new strategy for the prevention and treatment of OA

M.MooreR.CookM

Food Frontiers 2021, 2 (3), 294-304